Personal information

No personal information available

Activities

Collapse all

Works (15)

Perioperative outcomes in patients with myeloproliferative neoplasms: a multicentric analysis of 354 surgical procedures

Blood Vessels, Thrombosis & Hemostasis
2024-12 | Journal article
DOI: 10.1016/j.bvth.2024.100026
Contributors: Natasha Szuber; Harold J. Olney; Steve Dagenais Bellefeuille; Mégane Tanguay; Awatef Shehabeldeen; Saima Ahmed; Michaël Harnois; Jaroslav Prchal; Lambert Busque; Shireen Sirhan
Source: check_circle
Crossref

Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management

American Journal of Hematology
2024-07 | Journal article
DOI: 10.1002/ajh.27321
Contributors: Natasha Szuber; Attilio Orazi; Ayalew Tefferi
Source: check_circle
Crossref

CALR mutation burden in essential thrombocythemia and disease outcome

Blood
2024-03-28 | Journal article
DOI: 10.1182/blood.2023023428
Contributors: Paola Guglielmelli; Natasha Szuber; Naseema Gangat; Giulio Capecchi; Chiara Maccari; Michaël Harnois; Omer Karrar; Maymona Abdelmagid; Manjola Balliu; Elena Nacca et al.
Source: check_circle
Crossref

Sodium‐glucose co‐transporter‐2 inhibitor use and JAK2 unmutated erythrocytosis in 100 consecutive cases

American Journal of Hematology
2023-07 | Journal article
DOI: 10.1002/ajh.26933
Contributors: Naseema Gangat; Mostafa Abdallah; Natasha Szuber; Antoine Saliba; Hassan Alkhateeb; Aref Al‐Kali; Kebede H. Begna; Animesh Pardanani; Ayalew Tefferi
Source: check_circle
Crossref

JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management

American Journal of Hematology
2023-06 | Journal article
DOI: 10.1002/ajh.26920
Contributors: Naseema Gangat; Natasha Szuber; Ayalew Tefferi
Source: check_circle
Crossref

Perioperative management of myeloproliferative neoplasms: A pan‐Canadian physician survey and international expert opinion

American Journal of Hematology
2022-12 | Journal article
DOI: 10.1002/ajh.26739
Contributors: Natasha Szuber; Panagiota Toliopoulos; Lambert Busque; Sonia Cerquozzi; Lynda Foltz; Vikas Gupta; Ayalew Tefferi; Alessandro Maria Vannucchi; Christopher Hillis; Brian Leber et al.
Source: check_circle
Crossref

Site‐specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival

Journal of Thrombosis and Haemostasis
2022-10 | Journal article
DOI: 10.1111/jth.15834
Contributors: Naseema Gangat; Amritpal Singh; Natasha Szuber; Kebede Begna; Michelle Elliott; Alexandra Wolanskyj‐Spinner; Curtis A. Hanson; Animesh Pardanani; Valerio De Stefano; Tiziano Barbui et al.
Source: check_circle
Crossref

Myeloproliferative neoplasms – a global view

British Journal of Haematology
2022-09 | Journal article
DOI: 10.1111/bjh.18213
Contributors: Ayalew Tefferi; Jean‐Christophe Ianotto; Vikram Mathews; Jan Samuelsson; Natasha Szuber; Zhijian Xiao; Peter Hokland
Source: check_circle
Crossref

1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events

Blood Advances
2022-07-12 | Journal article
DOI: 10.1182/bloodadvances.2022007023
Contributors: Naseema Gangat; Natasha Szuber; Yamna Jadoon; Faiqa Farrukh; Kebede Begna; Michelle A. Elliott; Alexandra P. Wolanskyj-Spinner; Curtis A. Hanson; Animesh D. Pardanani; Valerio De Stefano et al.
Source: check_circle
Crossref

Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management

American Journal of Hematology
2022-04 | Journal article
DOI: 10.1002/ajh.26481
Contributors: Natasha Szuber; Michelle Elliott; Ayalew Tefferi
Source: check_circle
Crossref

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases

Blood Cancer Journal
2022-03-17 | Journal article
DOI: 10.1038/s41408-022-00639-z
Contributors: Naseema Gangat; Yamna Jadoon; Natasha Szuber; Curtis A. Hanson; Alexandra P. Wolanskyj-Spinner; Rhett P. Ketterling; Animesh Pardanani; Ayalew Tefferi
Source: check_circle
Crossref

A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series

American Journal of Hematology
2021-12 | Journal article
DOI: 10.1002/ajh.26377
Contributors: Caleb J. Smith; John W. Thomas; Gordon Ruan; Meredith C. Hyun; Radhika Bansal; Nicole McLaughlin; Animesh Pardanani; Naseema Gangat; Ronald S. Go; Natasha Szuber et al.
Source: check_circle
Crossref

Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera

Blood Cancer Journal
2021-04-15 | Journal article
DOI: 10.1038/s41408-021-00463-x
Contributors: Eliane Nguyen; Michaël Harnois; Lambert Busque; Shireen Sirhan; Sarit Assouline; Ines Chamaki; Harold Olney; Luigina Mollica; Natasha Szuber
Source: check_circle
Crossref

Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management

American Journal of Hematology
2020-02 | Journal article
DOI: 10.1002/ajh.25688
Contributors: Natasha Szuber; Michelle Elliott; Ayalew Tefferi
Source: check_circle
Crossref

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

American Journal of Hematology
2018-12 | Journal article
DOI: 10.1002/ajh.25270
Contributors: Natasha Szuber; Rangit R. Vallapureddy; Domenico Penna; Terra L. Lasho; Christy Finke; Curtis A. Hanson; Rhett P. Ketterling; Animesh Pardanani; Naseema Gangat; Ayalew Tefferi
Source: check_circle
Crossref

Peer review (13 reviews for 1 publication/grant)

Review activity for Blood cancer journal. (13)
How many people are using ORCID?